Haiyang Xie

6PUBLICATIONS
42CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Mechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 07, 2026
Engineering Immunoregenerative Therapy via an Immunomodulatory Binary Pharmacology Hydrogel Depot for Prolonged Allograft Survival.

|May 25, 2026
PGK1 Suppresses CD8+ T Cell-Mediated Antitumor Immunity Through CCL2/CCR2/Tumor-Associated Macrophages Axis in Hepatocellular Carcinoma.

|Aug 08, 2024
Blocking CX3CR1+ Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma.

Xiaonan Xiang, Kai Wang, Hui Zhang

|Aug 31, 2022
Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3.

Xingxin Zhu, Guangyuan Song, Shiyu Zhang

|Sep 20, 2019
The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.

Zhentian Xu, Haiyang Xie, Lin Zhou

|Jun 01, 2018
Partial Inhibition of HO-1 Attenuates HMP-Induced Hepatic Regeneration against Liver Injury in Rats.

Ning He, Jun-Jun Jia, Hai-Yang Xie

Pageof 1

Frequent Collaborators

4 joint publications

Shusen Zheng

2 joint publications

Lin Zhou

1 joint publications

Ning He

1 joint publications

Jun-Jun Jia